Ocular Therapeutix (OCUL) Preferred Shares (2013)

Ocular Therapeutix (OCUL) posted quarterly Preferred Shares of $8.5 million for Q4 2013.

Ocular Therapeutix (OCUL) Preferred Shares (2013) Analysis & Trends

Ocular Therapeutix has reported Preferred Shares for 1 years, with the latest figure at $8.5 million in Q4 2013.

Preferred Shares for Q4 2013 came in at $8.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2013 was $8.5 million (changed N/A YoY), and the FY2013 annual result was $8.5 million, down 64.29% from the prior year.
Preferred Shares held at $8.5 million in Q4 2013.
Over five years, Preferred Shares peaked at $8.5 million in Q4 2013 and troughed at $8.5 million in Q4 2013.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Ocular Therapeutix	2.20 Bn	2.20 Bn	11.46 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2013	8.49 Mn